Skip to main navigation Skip to search Skip to main content

Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party

  • J. Brijs*
  • , C. Peczynski
  • , W. Boreland
  • , A. Cuoghi
  • , J. Maertens
  • , M. Mohty
  • , N. Kröger
  • , P. Nakov
  • , A. E.C. Broers
  • , M. Eder
  • , C. Herrera Arroyo
  • , M. Kaufmann
  • , R. Ram
  • , N. P.M. Schaap
  • , C. Graham
  • , A. Mussetti
  • , O. Penack
  • , I. Moiseev
  • , Z. Peric
  • , H. Schoemans
  • *Corresponding author for this work
  • University Hospitals Leuven
  • Hôpital Saint-Antoine
  • European Society for Blood and Marrow Transplantation
  • Azienda Ospedaliero - Universitaria di Modena Policlinico
  • Immunology and Transplantation
  • Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat
  • University Hospital Schleswig-Holstein
  • Erasmus MC Cancer Institute
  • Medizinische Hochschule Hannover (MHH)
  • Reina Sofia Hosp, Hospital Universitario Reina Sofia, Liver Transplantat Unit
  • Robert-Bosch- Krankenhaus
  • Tel Aviv University
  • Department of Neurology
  • King's College London
  • Hospital Duran i Reynals
  • Institute for Radiology, CCM
  • Saint Petersburg State University
  • University Hospital Center Rijeka
  • KU Leuven

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)415-417
Number of pages3
JournalBone Marrow Transplantation
Volume60
Issue number3
DOIs
Publication statusPublished - Mar 2025

Cite this